Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine

EU orphan designation number: EU/3/05/332   
Active ingredient: 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Vion (UK) Limited, ? i3 Research
Sygnus Court , 22-32 Market Street, Maidenhead SL6 8AD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2005 Centralised Orphan - Designation EMEA/OD/066/05 (2005)5627 of 14/12/2005